Back
NuCana PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
42
NCNA
NuCana PLC
Last Price:
2.75
Seasonality Move:
-12.75%
Sell
44
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.03
Seasonality Move:
-8.14%
Sell
42
NuCana PLC (NCNA)
is a Sell
Is NuCana PLC a Buy, Sell or Hold?
- The current NuCana PLC [NCNA] share price is $2.75. The Score for NCNA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- NCNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.02. The Score for ADAP is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NCNA Stock Price Chart
What is NuCana PLC's stock price today?
-
The NuCana PLC share price today is $2.75
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NCNA is experiencing buying pressure, which is a positive indicator for future bullish movement.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $1.02
The current trend is relatively stagnant and ADAP is experiencing slight selling pressure.
NCNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.26 | Sell |
Relative Strength Index (14 RSI): | 38.05 | Sell |
Chaikin Money Flow: | 4605 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.74 - 3.38) | Sell |
Bollinger Bands (100): | (3.07 - 7.59) | Sell |
ADAP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 52.04 | Buy |
Chaikin Money Flow: | -245892 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.91 - 1.07) | Buy |
Bollinger Bands (100): | (0.99 - 1.45) | Sell |
NCNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.73 | Buy |
20-day SMA: | 2.93 | Sell |
50-day SMA: | 3.41 | Sell |
200-day SMA: | 8.06 | Sell |
8-day EMA: | 2.74 | Buy |
20-day EMA: | 2.95 | Sell |
50-day EMA: | 3.66 | Sell |
200-day EMA: | 8.48 | Sell |
ADAP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.96 | Buy |
20-day SMA: | 0.97 | Buy |
50-day SMA: | 1.06 | Sell |
200-day SMA: | 0.94 | Buy |
8-day EMA: | 0.99 | Buy |
20-day EMA: | 0.99 | Buy |
50-day EMA: | 1.05 | Sell |
200-day EMA: | 1.07 | Sell |
NuCana PLC Earnings Growth & NCNA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.84 per share, an increase next quarter of $0.09 per share, an increase this year of $2.64 per share, and a decrease next year of $3.67 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and a decrease next year of $0.17 per share.
NuCana PLC Technical Analysis
Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Adaptimmune Therapeutics PLC Technical Analysis
Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |